HLA-DR4 influences glial activity in Alzheimer's disease hippocampus

Paul S. Aisen, Alyssa Luddy, Martina Durner, J. F. Reinhard, Giulio Maria Pasinetti

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The importance of inflammatory/immune mechanisms in Alzheimer's disease is supported by evidence that the human leukocyte antigen (HLA)-DR genotype influences risk of the disease, with a protective effect associated with the HLA-DR4 allele. We investigated the influence of the HLA-DR4 allele on glial activity, assessed by quantification of glial fibrillary acidic protein (GFAP), in hippocampal tissue from subjects with Alzheimer's disease. The mean GFAP level was significantly higher in Alzheimer's disease hippocampal specimens lacking the HLA-DR4 allele compared to specimens with similar neuropathological findings that were HLA-DR4 positive. Apolipoprotein E genotype had no influence on GFAP levels. These results indicate that HLA- DR4 may exert a protective influence on Alzheimer's disease via modulation of glial activity.

Original languageEnglish
Pages (from-to)66-69
Number of pages4
JournalJournal of the Neurological Sciences
Volume161
Issue number1
DOIs
StatePublished - 26 Nov 1998

Keywords

  • Alzheimer's disease
  • Anti-inflammatory therapy
  • Astrocytes
  • GFAP
  • HLA-DR
  • Hippocampus
  • Inflammation

Fingerprint

Dive into the research topics of 'HLA-DR4 influences glial activity in Alzheimer's disease hippocampus'. Together they form a unique fingerprint.

Cite this